-transparent.png){kind=logo}
A series of 24 patients underwent 27 transtrigonal phenol injections for the treatment of bladder instability. Only 2 of 18 patients with detrusor instability and 2 of 6 with detrusor hyperreflexia continued to derive benefit from the procedure 6 months after it was carried out. Serious complications attributable to phenol were seen in 2 patients in this series and in a further 4 patients referred for complications resulting from this therapy in other centres. These results and a review of the literature lead us to suggest that transvesical phenol injection should not be used except in the hyper-reflexic bladder when no alternative treatment is possible. Particular care should be exercised in patients who have undergone extensive prior surgery or radiotherapy.
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
December 2008,
Current reviews in musculoskeletal medicine,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
July 1987,
Anaesthesia,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
December 1982,
British journal of urology,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
June 1983,
Lancet (London, England),
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
March 1993,
The Journal of prosthetic dentistry,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
March 1994,
The New Zealand dental journal,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
September 2016,
Neurology,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
January 2003,
The National medical journal of India,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
January 1988,
NATNews,
C R Chapple, and
S J Hampson, and
R T Turner-Warwick, and
P H Worth
January 2022,
General dentistry,
